Why is cephalexin more effective than trimethoprim‑sulfamethoxazole (Bactrim) for uncomplicated skin infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Cephalexin Works Better for Uncomplicated Skin Infections Because It Targets the Actual Pathogens

For uncomplicated, nonpurulent cellulitis, cephalexin is the appropriate first-line choice because β-hemolytic streptococci (not MRSA) are the predominant pathogens, and adding Bactrim provides no clinical benefit while increasing cost and side effects. 1

The Core Issue: Pathogen Mismatch

The question assumes Bactrim "doesn't work as well," but the reality is more nuanced:

For Nonpurulent Cellulitis (No Abscess/Drainage):

  • β-hemolytic streptococci are the primary pathogens 2
  • Cephalexin has excellent streptococcal coverage 3
  • Bactrim has poor to no activity against streptococci 4
  • The landmark 2017 JAMA trial definitively showed that adding TMP-SMX to cephalexin provided no improvement in cure rates (83.5% vs 85.5%, p=0.50) 1

For Purulent Infections (Abscesses, Furuncles):

  • Staphylococcus aureus (including MRSA) dominates 2
  • Here, Bactrim actually performs well when combined with adequate drainage 5
  • However, drainage is more important than antibiotic choice - the 2011 pediatric trial showed no difference between cephalexin and clindamycin when 97% of abscesses were drained (94% vs 97% improvement, p=0.50) 6

The Evidence Hierarchy

IDSA Guidelines (2014) provide the framework 2:

  • For impetigo/ecthyma with methicillin-susceptible S. aureus: cephalexin or dicloxacillin recommended (strong, high quality evidence)
  • Reserve TMP-SMX for confirmed or suspected MRSA only (strong, moderate evidence)
  • Streptococcal infections should use penicillin or cephalosporins

FDA labeling confirms 3, 4:

  • Cephalexin is indicated for skin infections caused by S. aureus and S. pyogenes
  • Bactrim's FDA-approved indications do not include routine skin/soft tissue infections - it lists UTIs, otitis media, bronchitis, shigellosis, PCP, and traveler's diarrhea

Clinical Algorithm

Step 1: Classify the infection

  • Purulent (abscess, furuncle, carbuncle with pus) → Consider MRSA
  • Nonpurulent (cellulitis, erysipelas without drainage) → Think streptococci

Step 2: For nonpurulent cellulitis

  • Use cephalexin 500mg four times daily for 7 days 2, 3
  • Do NOT add TMP-SMX empirically 1
  • Reserve MRSA coverage only if: patient fails initial therapy, has risk factors (injection drug use, known MRSA colonization), or culture confirms MRSA

Step 3: For purulent infections

  • Incision and drainage is paramount 6
  • Either cephalexin OR TMP-SMX is reasonable if MRSA prevalence is high 5
  • Close follow-up at 48-72 hours matters more than initial antibiotic choice 6

Common Pitfalls

Pitfall #1: Assuming all skin infections need MRSA coverage

  • The 2017 trial showed this is wrong for nonpurulent cellulitis 1
  • Cost-effectiveness analysis demonstrates cephalexin remains optimal at current MRSA prevalence levels (27%) 7
  • Clindamycin only becomes cost-effective when MRSA probability exceeds 41-80% AND staphylococcal infection probability exceeds 40% 7

Pitfall #2: Using Bactrim for streptococcal coverage

  • Bactrim has inadequate streptococcal activity 4
  • This is why it's not FDA-approved for routine skin infections 4

Pitfall #3: Neglecting adequate drainage

  • In the pediatric trial, 97% drainage rates led to 94-97% cure regardless of antibiotic 6
  • Antibiotics are adjunctive for purulent infections; drainage is definitive

When Bactrim IS Appropriate

  • Confirmed MRSA on culture 2
  • Failed initial β-lactam therapy suggesting resistant organism
  • Documented allergy to β-lactams
  • Purulent infections in areas with high MRSA prevalence (>30-40%) where drainage is performed 5

The Bottom Line on Effectiveness

Cephalexin doesn't necessarily "work better" universally - it works better for the infections it's designed to treat (streptococcal cellulitis). Bactrim works well for MRSA but fails against streptococci. Since nonpurulent cellulitis is predominantly streptococcal, and most purulent infections respond to drainage alone, cephalexin remains the evidence-based first-line choice for uncomplicated skin infections 2, 1.

References

Related Questions

Can I take Bactrim (trimethoprim‑sulfamethoxazole) and Keflex (cephalexin) for a 14‑day course to treat a wound infection?
Can cephalexin be used for an uncomplicated infected leg wound in a patient without β‑lactam allergy or MRSA/Pseudomonas risk factors, and what is the appropriate treatment duration?
What is the appropriate antibiotic regimen for cellulitis secondary to a metal abrasion: trimethoprim‑sulfamethoxazole (Bactrim) versus cephalexin versus amoxicillin‑clavulanate (Augmentin)?
Can I take Bactrim (trimethoprim‑sulfamethoxazole) and Keflex (cephalexin) while on Wellbutrin (bupropion)?
What is the appropriate treatment for cellulitis at a cesarean section incision in a postpartum woman without a penicillin allergy, including coverage for possible MRSA?
How should a slightly thickened thyroid isthmus be investigated and managed?
What are the steps of performing a Shirodkar cervical cerclage?
What is the appropriate surgical management for a patient with intra‑hepatic biliary radical dilation and proximal common bile duct dilation?
What is the appropriate sliding‑scale insulin aspart dosing for pre‑meal blood glucose levels of 181‑230 mg/dL, 231‑280 mg/dL, 281‑330 mg/dL, and 331‑380 mg/dL?
After a blood donation that reduced ferritin from 25 ng/mL to 15 ng/mL, how long will it take for ferritin to rise above 50 ng/mL?
What questions should be asked during a well‑woman visit for a 30‑year‑old female?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.